H. Chung

发表

A prospective comparison of MRI‐US fused targeted biopsy versus systematic ultrasound‐guided biopsy for detecting clinically significant prostate cancer in patients on active surveillance

G. Pond, M. Haider, L. Klotz, 2015, Journal of magnetic resonance imaging : JMRI.

Can all centers plan intensity-modulated radiotherapy (IMRT) effectively? An external audit of dosimetric comparisons between three-dimensional conformal radiotherapy and IMRT for adjuvant chemoradiation for gastric cancer.

Ping Xia, P. Xia, Jiade J Lu, 2008, International journal of radiation oncology, biology, physics.

Audiologic and treatment outcomes after linear accelerator-based stereotactic irradiation for acoustic neuroma.

B. Clark, M. Mckenzie, J. Robar, 2004, International journal of radiation oncology, biology, physics.

Stereotactic Radiotherapy for Pancreatic Cancer: A Single-Institution Experience

Y. Ung, A. Karotki, R. Korol, 2020, Cureus.

Elective nodal ultra hypofractionated radiation for prostate cancer: safety and efficacy from four prospective clinical trials.

Hans T. Chung, Liying Zhang, P. Cheung, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Phase 1-2 Study of Stereotactic Ablative Radiotherapy Including Regional Lymph Node Irradiation in Patients With High-Risk Prostate Cancer (SATURN): Early Toxicity and Quality of Life.

Liying Zhang, P. Cheung, L. D'alimonte, 2018, International journal of radiation oncology, biology, physics.

Strategies to tackle the challenges of external beam radiotherapy for liver tumors

M. Lock, N. Mayr, S. Lo, 2017, World journal of hepatology.

Stereotactic body radiotherapy: an effective local treatment modality for hepatocellular carcinoma.

M. Lock, Zhibin Huang, N. Mayr, 2014, Future oncology.

Outcomes of extra-cranial stereotactic body radiotherapy for metastatic colorectal cancer: Dose and site of metastases matter.

Hans T. Chung, Liying Zhang, I. Poon, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Phase I-III development of the EORTC QLQ-ANL27, a health-related quality of life questionnaire for anal cancer.

Hans T. Chung, K. Tomaszewski, V. Vassiliou, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Outcomes of extra-cranial stereotactic body radiotherapy for metastatic breast cancer: Treatment indication matters.

Hans T. Chung, I. Poon, A. Louie, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Multisite stereotactic body radiotherapy for metastatic non-small-cell lung cancer: Delaying the need to start or change systemic therapy?

Hans T. Chung, Liying Zhang, I. Poon, 2018, Lung cancer.

Local control and fracture risk following stereotactic body radiation therapy for non-spine bone metastases.

Hans T. Chung, A. Kiss, I. Poon, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Accelerating prostate stereotactic ablative body radiotherapy: Efficacy and toxicity of a randomized phase II study of 11 versus 29 days overall treatment time (PATRIOT).

Hans T. Chung, Liying Zhang, B. McCurdy, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Once-weekly versus every-other-day stereotactic body radiotherapy in patients with prostate cancer (PATRIOT): A phase 2 randomized trial.

Liying Zhang, B. McCurdy, P. Cheung, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Two-fraction stereotactic ablative radiotherapy with simultaneous boost to MRI-defined dominant intra-prostatic lesion - results from the 2SMART Phase 2 trial.

Liying Zhang, P. Cheung, M. McGuffin, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or Brachytherapy.

Hans T. Chung, G. Pond, M. Lock, 2019, International journal of radiation oncology, biology, physics.

A prospective cohort study of patient-reported vomiting, retching, nausea and antiemetic use during neoadjuvant long-course radiation therapy and concurrent 5-fluorouracil-based chemotherapy for rectal adenocarcinoma

Hans T. Chung, C. Wong, N. Coburn, 2018, Clinical and Translational Radiation Oncology.

Clinical evaluation of an MRI-to-ultrasound deformable image registration algorithm for prostate brachytherapy.

Ananth Ravi, Melanie Davidson, Chia-Lin Tseng, 2019, Brachytherapy.

A pilot study with palonosetron in the prophylaxis of radiation-induced nausea and vomiting.

Hans T. Chung, Liying Zhang, M. Tsao, 2018, Annals of palliative medicine.

Computed Tomography Evaluation of Density Following Stereotactic Body Radiation Therapy of Nonspine Bone Metastases

Hans T. Chung, I. Poon, A. Sahgal, 2016, Technology in cancer research & treatment.

Stereotactic body radiation therapy for non-spine bone metastases--a review of the literature.

Hans T. Chung, I. Poon, A. Sahgal, 2015, Annals of palliative medicine.

Pelvic insufficiency fractures in women following radiation treatment: a case series.

Hans T. Chung, A. Yee, E. Chow, 2016, Annals of palliative medicine.

A pilot study of endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging changes with dutasteride in patients with low risk prostate cancer

J. Kurhanewicz, V. Weinberg, S. Noworolski, 2011, BJU international.

Evaluation of a radiotherapy protocol based on INT0116 for completely resected gastric adenocarcinoma.

T. Shakespeare, R. Mukherjee, M. Back, 2003, International journal of radiation oncology, biology, physics.

Developing and Evaluating Multimedia Patient Education Tools to Better Prepare Prostate-Cancer Patients for Radiotherapy Treatment (Randomized Study)

P. Cheung, E. Szumacher, Xingshan Cao, 2018, Journal of Cancer Education.

Temporal Changes in IMRT Contouring of Organs at Risk for Nasopharyngeal Carcinoma — The Learning Curve Blues and a Tool that Could Help

Hans T. Chung, S. Baxi, V. Chong, 2009, Technology in cancer research & treatment.

Impact of Magnetic Resonance Imaging on Gross Tumor Volume Delineation in Non-spine Bony Metastasis Treated With Stereotactic Body Radiation Therapy.

I. Poon, A. Sahgal, H. Soliman, 2018, International journal of radiation oncology, biology, physics.

Radiological changes on CT after stereotactic body radiation therapy to non-spine bone metastases: a descriptive series.

Hans T. Chung, I. Poon, A. Sahgal, 2016, Annals of palliative medicine.

Tumor Response After Stereotactic Body Radiation Therapy to Nonspine Bone Metastases: An Evaluation of Response Criteria.

Hans T. Chung, I. Poon, A. Sahgal, 2015, International journal of radiation oncology, biology, physics.

A comparative study of patient-reported outcomes after contemporary radiation techniques for prostate cancer.

Hans T. Chung, A. Kiss, A. Bezjak, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

MRI assisted focal boost integrated with HDR monotherapy study in low and intermediate risk prostate cancer (MARS): Results from a phase II clinical trial.

Laura D'Alimonte, Hans T. Chung, Ananth Ravi, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Stereotactic pelvic radiotherapy with HDR boost for dose escalation in intermediate and high-risk prostate cancer (SPARE): efficacy, toxicity and quality of life.

Liying Zhang, P. Cheung, D. Vesprini, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The correlation of clinical lacrimal bone density and thickness, established at the time of DCR surgery, with systemic bone mineral densitometry testing

J. Oestreicher, J. Hurwitz, H. Chung, 2000, Orbit.

5-Year Outcomes of a Prospective Phase 1/2 Study of Accelerated Hypofractionated Radiation Therapy to the Prostate Bed.

Liying Zhang, P. Cheung, A. Gladwish, 2019, Practical radiation oncology.

Management of radiation-induced nausea and vomiting with palonosetron in patients with pre-existing emesis: a pilot study.

Hans T. Chung, Liying Zhang, M. Tsao, 2018, Annals of palliative medicine.

Dosimetric impact of inter-observer catheter reconstruction variability in ultrasound-based high-dose-rate prostate brachytherapy.

Hans T. Chung, L. D'alimonte, J. Murgić, 2017, Brachytherapy.

Does image-guided radiotherapy improve toxicity profile in whole pelvic-treated high-risk prostate cancer? Comparison between IG-IMRT and IMRT.

P. Xia, M. Roach, H. Chung, 2009, International journal of radiation oncology, biology, physics.

Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy.

Hans T. Chung, Liying Zhang, P. Cheung, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

4DCT Simulation With Synchronized Contrast Injection in Liver SBRT Patients

L. Milot, A. Karotki, W. Chu, 2016, Technology in cancer research & treatment.

The clinical significance of persistent cancer cells on prostate biopsy after high-dose-rate brachytherapy boost for intermediate-risk prostate cancer.

Liying Zhang, G. Morton, A. Deabreu, 2015, Brachytherapy.

Symptom clusters of gastrointestinal cancer patients undergoing radiotherapy using the Functional Living Index—Emesis (FLIE) quality-of-life tool

Liying Zhang, M. Popovic, M. Poon, 2015, Supportive Care in Cancer.

A prospective study of gastrointestinal radiation therapy-induced nausea and vomiting

Hans T. Chung, Liying Zhang, M. Popovic, 2014, Supportive Care in Cancer.

Is single fraction 15 Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer?

Liying Zhang, É. Vigneault, P. Cheung, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The correlation of clinical lacrimal bone density and thickness, established at the time of DCR surgery, with systemic bone mineral densitometry testing.

J. Oestreicher, J. Hurwitz, H. Chung, 2000 .

Metastatic progression following multimodal therapy for unfavorable-risk prostate cancer.

G. Rodrigues, P. Cheung, G. Morton, 2021, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Dosimetric evaluation of MRI-to-ultrasound automated image registration algorithms for prostate brachytherapy.

Hans T. Chung, G. Morton, A. Loblaw, 2020, Brachytherapy.

Predictive Parameters of Symptomatic Hematochezia Following 5-Fraction Gantry-Based SABR in Prostate Cancer.

Liying Zhang, P. Cheung, D. Vesprini, 2016, International journal of radiation oncology, biology, physics.

High dose-rate brachytherapy boost for intermediate risk prostate cancer: Long-term outcomes of two different treatment schedules and early biochemical predictors of success.

Hans T. Chung, Liying Zhang, P. Cheung, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

PATRIOT Trial: Randomized phase II study of prostate stereotactic body radiotherapy comparing 11 versus 29 days overall treatment time.

Liying Zhang, B. McCurdy, P. Cheung, 2015 .

Success of targeted transperineal biopsy in patients on surveillance for grade group 1 prostate cancer.

P. Cheung, E. Szumacher, D. Vesprini, 2022, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Quantitative Ultrasound Spectroscopic Imaging for Characterization of Disease Extent in Prostate Cancer Patients1

Michael C. Kolios, Hans T. Chung, M. Yaffe, 2015, Translational oncology.

Perfusion imaging of colorectal liver metastases treated with bevacizumab and stereotactic body radiotherapy

L. Milot, G. Czarnota, Y. Ko, 2018, Physics and imaging in radiation oncology.

Radiation treatment of bladder squamous cell carcinoma in a patient with spina bifida: A case report.

G. Morton, H. Chung, N. D'souza, 2012, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Use of cone-beam imaging to correct for catheter displacement in high dose-rate prostate brachytherapy.

D Andrew Loblaw, G. Morton, D. Loblaw, 2011, Brachytherapy.

Quality of life changes after stereotactic ablative radiotherapy for liver metastases: A prospective cohort analysis.

Hans T. Chung, Kelvin K. W. Chan, G. Rodrigues, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A novel prospective descriptive analysis of nausea and vomiting among patients receiving gastrointestinal radiation therapy

Liying Zhang, M. Poon, E. Chow, 2016, Supportive Care in Cancer.

A comparative study of quality of life in patients with localized prostate cancer treated at a single institution: stereotactic ablative radiotherapy or external beam+high dose rate brachytherapy boost.

Liying Zhang, P. Cheung, G. Morton, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Conventional vs machine learning-based treatment planning in prostate brachytherapy: Results of a Phase I randomized controlled trial.

Hans T. Chung, G. Morton, A. Loblaw, 2020, Brachytherapy.

Salvage Prostate Brachytherapy in Radiorecurrent Prostate Cancer: An International Delphi Consensus Study.

I. Hsu, L. Potters, M. Zelefsky, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Defining radio-recurrent intra-prostatic target volumes using PSMA-targeted PET/CT and multi-parametric MRI

A. Ward, G. Bauman, Z. Kassam, 2021, Clinical and Translational Radiation Oncology.

Stereotactic Ablative Radiotherapy for the Management of Liver Metastases from Neuroendocrine Neoplasms: A Preliminary Study

Hans T. Chung, S. Singh, J. Hallet, 2021, Neuroendocrinology.

Estimating acute urinary retention risk post prostate high dose-rate (HDR) brachytherapy: A clinical-based recursive partitioning analysis.

G. Morton, A. Loblaw, A. Ravi, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Does ADT benefit unfavourable intermediate risk prostate cancer patients treated with brachytherapy boost and external beam radiotherapy? A propensity-score matched analysis.

Hans T. Chung, G. Rodrigues, A. Warner, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Elective pelvic nodal irradiation with a simultaneous hypofractionated integrated prostate boost for localized high risk prostate cancer: Long term results from a prospective clinical trial.

Liying Zhang, P. Cheung, E. Szumacher, 2021, Radiotherapy and Oncology.

Pattern of relapse and dose received by the recurrent intraprostatic nodule in low- to intermediate-risk prostate cancer treated with single fraction 19 Gy high-dose-rate brachytherapy.

Hans T. Chung, P. Cheung, M. McGuffin, 2017, Brachytherapy.

Prostate high dose-rate brachytherapy as monotherapy for prostate cancer: late toxicity and patient reported outcomes from a randomized phase II clinical trial.

Hans T. Chung, Liying Zhang, P. Cheung, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Focal Salvage High Dose-Rate Brachytherapy for Locally Recurrent Prostate Cancer After Primary Radiation Therapy Failure: Results From a Prospective Clinical Trial.

Liying Zhang, M. Haider, J. Murgić, 2018, International journal of radiation oncology, biology, physics.

Internal audit of a comprehensive IMRT program for prostate cancer: a model for centers in developing countries?

R. Mukherjee, Wei Ren, W. Koh, 2009, International journal of radiation oncology, biology, physics.

In Regard to van Son et al.

J. Murgić, H. Chung, 2021, International journal of radiation oncology, biology, physics.

Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Early toxicity and quality-of life results from a randomized phase II clinical trial of one fraction of 19Gy or two fractions of 13.5Gy.

Hans T. Chung, Liying Zhang, P. Cheung, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Three-dimensional volumetric analysis of irradiated lung with adjuvant breast irradiation.

Hans T. Chung, Liang Shen, A. Teh, 2009, International journal of radiation oncology, biology, physics.

Hans T. Chung, Liying Zhang, P. Cheung, 2011, International journal of radiation oncology, biology, physics.

The American Brachytherapy Society and the American Radium Society Appropriate Use Criteria Genitourinary Committee Endorse the American Society of Clinical Oncology/Cancer Care Ontario Guidelines.

M. Zelefsky, M. Keyes, É. Vigneault, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Developing and Evaluating Multimedia Patient Education Tools to Better Prepare Prostate-Cancer Patients for Radiotherapy Treatment (Randomized Study)

P. Cheung, E. Szumacher, Xingshan Cao, 2016, Journal of Cancer Education.

Fasanella-Servat procedure: indications, efficacy, and complications.

J. Harvey, J. Oestreicher, N. K. Pang, 2008, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

Two-fraction stereotactic ablative radiotherapy (SABR) versus two-fraction high dose rate (HDR) brachytherapy for localized prostate cancer: Does dose heterogeneity matter?

Liying Zhang, P. Cheung, M. McGuffin, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Outcomes of Adjuvant Chemoradiotherapy After a Radical Gastrectomy and a D2 Node Dissection for Gastric Adenocarcinoma

J. Tey, J. So, T. Shakespeare, 2008, Cancer journal.

Diagnosis, referral, and primary treatment decisions in newly diagnosed prostate cancer patients in a multidisciplinary diagnostic assessment program.

P. Cheung, C. Danjoux, G. Morton, 2016, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Improving prostate cancer care collaboratively - a multidisciplinary, formal, consensus-based approach.

Hans T. Chung, D. Vesprini, A. Loblaw, 2017, The Canadian journal of urology.

PATRIOT Trial: Randomized Phase 2 Study of Prostate Stereotactic Body Radiation Therapy Comparing 11 Versus 29 Days Overall Treatment Time

B. McCurdy, P. Cheung, D. Vesprini, 2015 .

Two StereoTactic ablative radiotherapy treatments for localized prostate cancer (2STAR): Results from a prospective clinical trial.

Liying Zhang, P. Cheung, W. Chu, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Multipurpose ultrasound-based prostate phantom for use in interstitial brachytherapy.

G. Morton, A. Loblaw, A. Ravi, 2021, Brachytherapy.

Intraoperative ultrasound-based planning can effectively replace postoperative CT-based planning for high-dose-rate brachytherapy for prostate cancer.

G. Morton, A. Loblaw, D. Batchelar, 2016, Brachytherapy.

Genintourinary Oncology Intraoperative ultrasound-based planning can effectively replace postoperative CT-based planning for high-dose-rate brachytherapy for prostate cancer

G. Morton, A. Loblaw, D. Batchelar, 2016 .

Prostate HDR Monotherapy: Initial Efficacy Results from a Randomized Trial of One versus Two Fractions

Liying Zhang, M. McGuffin, G. Morton, 2017 .

Predictive parameters of symptomatic haematochezia following 5-fraction gantry-based SABR in prostate cancer.

Hans T. Chung, Liying Zhang, P. Cheung, 2016 .

Evaluation of a Machine-Learning Algorithm for Treatment Planning in Prostate Low-Dose-Rate Brachytherapy.

Ananth Ravi, Emily Heath, Lin Lu, 2017, International journal of radiation oncology, biology, physics.

Two versus five stereotactic ablative radiotherapy treatments for localized prostate cancer: A quality of life analysis of two prospective clinical trials.

Liying Zhang, B. McCurdy, P. Cheung, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

SABR in High-Risk Prostate Cancer: Outcomes From 2 Prospective Clinical Trials With and Without Elective Nodal Irradiation.

Hans T. Chung, Liying Zhang, P. Cheung, 2019, International journal of radiation oncology, biology, physics.

Empowering Patients Through Education—Development and Evaluation of a Multimedia Patient Education Tool to Ensure Patient Preparedness for Planning CT Scan for Prostate Cancer (Randomized Study)

P. Cheung, E. Szumacher, Xingshan Cao, 2016 .

Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer.

Liying Zhang, P. Cheung, M. McGuffin, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Long-term Toxicity and Health-related Quality of Life after Single-fraction High Dose Rate Brachytherapy Boost and Hypofractionated External Beam Radiotherapy for Intermediate-risk Prostate Cancer.

Liying Zhang, P. Cheung, C. Danjoux, 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).

Comparison of Biochemical and Toxicity Outcomes From a Contemporaneous Cohort Study of Low-Risk Prostate Cancer Treated With Different Radiation Techniques

Hans T. Chung, P. Cheung, L. D'alimonte, 2013 .

Dosimetric comparison of volumetric modulated arc therapy and intensity-modulated radiation therapy for liver stereotactic ablative body radiotherapy

Hans T. Chung, W. Chu, R. Korol, 2016, Journal of Radiation Oncology.

Comparison of acute toxicity in patients treated with a 4-field box or IMRT to deliver elective pelvic nodal irradiation for localized high-risk prostate cancer.

Liying Zhang, A. Sahgal, P. Cheung, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Accelerated hypofractioned postoperative radiotherapy for prostate cancer: a prospective phase I/II study.

P. Cheung, A. Gladwish, G. Morton, 2015, Clinical oncology (Royal College of Radiologists (Great Britain)).

Best of International Stereotactic Radiosurgery Society Congress 2013: stereotactic body radiation therapy. Part I: spinal tumors.

Hans T. Chung, B. Slotman, S. Ryu, 2013, Future oncology.

A Comparative Study of Quality of Life in Patients with Localized Prostate Cancer Treated in a Single Institution: Stereotactic Radiotherapy or External Beam + High-Dose-Rate Brachytherapy Boost

Hans T. Chung, Liying Zhang, P. Cheung, 2014 .

A pilot study of everolimus and radiation for neuroendocrine liver metastases.

L. Milot, S. Singh, Hanbo Chen, 2021, Endocrine-related cancer.

Liying Zhang, P. Cheung, G. Morton, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Do patients receiving pelvic radiation and anti-emetics experience diarrhea and/or constipation?

Hans T. Chung, M. Tsao, E. Chow, 2017, Annals of palliative medicine.

58: Acute Quality of Life Changes after Stereotactic Ablative Radiotherapy for Liver Metastasis: A Prospective Cohort Analysis

Hans T. Chung, Kelvin K. W. Chan, G. Rodrigues, 2016 .

Local control and fracture risk following stereotactic body radiation therapy for non-spine bone metastases.

A. Kiss, I. Poon, A. Sahgal, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Post-implant dosimetry of permanent prostate brachytherapy: comparison of MRI-only and CT-MRI fusion based workflows.

G. Stanisz, G. Morton, C. Tseng, 2019, International journal of radiation oncology, biology, physics.

The effect of radiation technique and bladder filling on the acute toxicity of pelvic radiotherapy for localized high risk prostate cancer.

Hans T. Chung, Liying Zhang, A. Sahgal, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Utilization of Salvage and Systemic Therapies for Recurrent Prostate Cancer as a Result of 18F-DCFPyL PET/CT Restaging

G. Pond, M. Lock, A. Berlin, 2020, Advances in radiation oncology.

Changes in ADC and T2-weighted MRI-derived radiomic features in patients treated with focal salvage HDR prostate brachytherapy for local recurrence after previous external-beam radiotherapy.

Hans T. Chung, M. Haider, J. Murgić, 2018, Brachytherapy.

Liying Zhang, P. Cheung, C. Danjoux, 2011, International journal of radiation oncology, biology, physics.